{
    "id": 27070,
    "fullName": "TP53 P278H",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "TP53 P278H lies within the DNA-binding domain of the Tp53 protein (PMID: 15510160). P278H has been identified in the scientific literature (PMID: 27022024, PMID: 25151357, PMID: 30978502), but has not been biochemically characterized and therefore, its effect on Tp53 protein function is unknown (PubMed, Mar 2020).",
            "references": [
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 1252,
                    "pubMedId": 25151357,
                    "title": "Genetic landscape of esophageal squamous cell carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25151357"
                },
                {
                    "id": 12832,
                    "pubMedId": 27022024,
                    "title": "Modeling the Etiology of p53-mutated Cancer Cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27022024"
                },
                {
                    "id": 5145,
                    "pubMedId": 15510160,
                    "title": "Post-translational modification of p53 in tumorigenesis.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/15510160"
                },
                {
                    "id": 15732,
                    "pubMedId": 30978502,
                    "title": "Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30978502"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 7157,
        "geneSymbol": "TP53",
        "terms": [
            "TP53",
            "BCC7",
            "BMFS5",
            "LFS1",
            "P53",
            "TRP53"
        ]
    },
    "variant": "P278H",
    "createDate": "10/05/2017",
    "updateDate": "03/12/2020",
    "referenceTranscriptCoordinates": {
        "id": 95082,
        "transcript": "NM_000546",
        "gDna": "chr17:g.7673787G>T",
        "cDna": "c.833C>A",
        "protein": "p.P278H",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 17689,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase II clinical trial, a patient with non-small cell lung cancer harboring a ROS1 rearrangement demonstrated progression while being treated with Xalkori (crizotinib), and was found to have acquired two mutations, ROS1 L2026M and TP53 P278H (PMID: 30978502; NCT02183870).",
            "molecularProfile": {
                "id": 32740,
                "profileName": "TP53 P278H ROS1 L2026M ROS1 rearrange"
            },
            "therapy": {
                "id": 706,
                "therapyName": "Crizotinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 15732,
                    "pubMedId": 30978502,
                    "title": "Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30978502"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28455,
            "profileName": "TP53 P278H",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 32740,
            "profileName": "TP53 P278H ROS1 L2026M ROS1 rearrange",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 95084,
            "transcript": "NM_001126114",
            "gDna": "chr17:g.7673787G>T",
            "cDna": "c.833C>A",
            "protein": "p.P278H",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 95083,
            "transcript": "NM_001126113",
            "gDna": "chr17:g.7673787G>T",
            "cDna": "c.833C>A",
            "protein": "p.P278H",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 95081,
            "transcript": "NM_001126112",
            "gDna": "chr17:g.7673787G>T",
            "cDna": "c.833C>A",
            "protein": "p.P278H",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 95082,
            "transcript": "NM_000546",
            "gDna": "chr17:g.7673787G>T",
            "cDna": "c.833C>A",
            "protein": "p.P278H",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}